Synthesis and Evaluation as PDE4 Inhibitors of Pyrimidine-2,4-dione Derivatives

被引：3

作者：

Giovannoni, Maria P. ^{[1
]}

Graziano, Alessia ^{[1
]}

Matucci, Rosanna ^{[2
]}

Nesi, Marta ^{[2
]}

Cesari, Nicoletta ^{[1
]}

Vergelli, Claudia ^{[1
]}

Biancalani, Claudio ^{[1
]}

Crocetti, Letizia ^{[1
]}

Cilibrizzi, Agostino ^{[1
]}

Dal Piaz, Vittorio ^{[1
]}

机构：

[1] Dipartimento Sci Farmaceut, I-50019 Florence, Italy

[2] Dipartimento Farmacol Preclin & Clin MA Mancini, Florence, Italy

来源：

DRUG DEVELOPMENT RESEARCH | 2011年 / 72卷 / 03期

关键词：

HARBS; PDE4; selectivity; CROSS-COUPLING REACTIONS; PHOSPHODIESTERASE-4; INHIBITORS; C-N; POTENT; ROLIPRAM; BINDING; SUPPRESSION; THALIDOMIDE; EXPRESSION; ANALOGS;

D O I：

10.1002/ddr.20395

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of nitraquazone analogs with a pyrimidindione core was synthesized and tested for inhibitory activity on PDE4, selectivity versus PDE3 and PDE5 and for affinity towards the rolipram high-affinity binding site (HARBS). The 5-anilino derivatives 13-18 showed the best profile combining appreciable PDE4 inhibitory activity (IC50 = 5-14 mu M) with a good selectivity toward PDE3 and PDE5. The same compounds demonstrate low affinity for the HARBS site with IC50 values of 12-69 mu M (IC50 for Rolipram = 3.6 nM). Drug Dev Res 72:274-288, 2011. (C) 2010 Wiley-Liss, Inc.

引用

页码：274 / 288

页数：15

共 50 条

[31] Structural exploration, synthesis and pharmacological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives as iNOS inhibitors against inflammatory diseases
Ma, Liang
Pei, Heying
Lei, Lei
He, Linhong
Chen, Jinying
Liang, Xiaolin
Peng, Aihua
Ye, Haoyu
Xiang, Mingli
Chen, Lijuan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 92 : 178 - 190
[32] Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors
Liang, Xiao
Fu, Huansheng
Xiao, Peng
Fang, Hao
Hou, Xuben
BIOORGANIC CHEMISTRY, 2020, 103
[33] Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors
Ha, Young Mi
Park, Yun Jung
Kim, Jin-Ah
Park, Daeui
Park, Ji Young
Lee, Hye Jin
Lee, Ji Yeon
Moon, Hyung Ryong
Chung, Hae Young
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 49 : 245 - 252
[34] Investigation of Thiazolidine-2,4-Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies
Naeimi, Hanane
Taheri, Maryam
Ghafouri, Hossein
Mohammadi, Asadollah
CHEMISTRYOPEN, 2025,
[35] Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors
Almatary, Aya M.
Elmorsy, Mohammad A.
El Husseiny, Walaa M.
Selim, Khalid B.
El-Sayed, Magda A-A.
ARCHIV DER PHARMAZIE, 2018, 351 (3-4)
[36] Synthesis and in vivo hypoglycemic activity of new imidazolidine-2,4-dione derivatives
Hussain, Abid
Kashif, Muhammad Kalim
Naseer, Muhammad Moazzam
Rana, Usman A.
Hameed, Shahid
RESEARCH ON CHEMICAL INTERMEDIATES, 2015, 41 (10) : 7313 - 7326
[37] Synthesis and Antimicrobial Activities of 5-Arylidene-thiazolidine-2,4-dione Derivatives
da Silva, Ivanildo Mangueira
da Silva Filho, Joao
da Silva Santiago, Priscila Brandao Gomes
do Egito, Micalyne Soares
de Souza, Carlos Andre
Gouveia, Frederico Leite
Ximenes, Rafael Matos
da Fonseca Ribeiro de Sena, Kesia Xisto
de Faria, Antonio Rodolfo
Brondani, Dalci Jose
Cavalcanti de Albuquerque, Julianna Ferreira
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[38] Synthesis and Antimicrobial Activity of Some Novel Thiazolidine-2,4-dione Derivatives
Mentese, Arzu
Ceylan-Unlusoy, Meltem
Bozdag-Dundar, Oya
Altanlar, Nurten
Ertan, Rahmiye
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (12): : 659 - 665
[39] Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors
Wang, Gang
Wang, Yutao
Wang, Lei
Han, Leiqiang
Hou, Xuben
Fu, Huansheng
Fang, Hao
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (23) : 7359 - 7365
[40] Substituted indazole derivatives and their use as inhibitors of PDE4 and the production of tumour necrosis factor
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 1053 - 1056

← 1 2 3 4 5 →